Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osheroff

Showing results (61-70 of 362) with videos related to

Pageof 37
Sort By:
The Journal of Biological Chemistry|February 13, 1999
In vitro evolution of preferred topoisomerase II DNA cleavage sitesD A Burden, N Osheroff
Chemical Research in Toxicology|February 26, 2008
(-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerasesOmari J Bandele, Neil Osheroff
Phytochemistry Reviews : Proceedings of the Phytochemical Society of Europe|March 29, 2014
Phytochemicals as Anticancer and Chemopreventive Topoisomerase II PoisonsAdam C Ketron, Neil Osheroff
ACS Infectious Diseases|January 27, 2026
Enzyme-DNA Interactions Affect the Catalytic Inhibition of Mycobacterial Gyrases by Antibacterial DrugsJillian F Armenia, Neil Osheroff
ACS Infectious Diseases|April 2, 2024
Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone ResistanceJessica A Collins, Neil Osheroff
Biochemistry|July 14, 1987
Calcium-promoted DNA cleavage by eukaryotic topoisomerase II: trapping the covalent enzyme-DNA complex in an active formN Osheroff, E L Zechiedrich
Biochemistry|August 24, 2005
Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzymeJennifer S Dickey, Neil Osheroff
Biochemistry|March 1, 2006
The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugsA Kathleen McClendon, Neil Osheroff
Progress in Nucleic Acid Research and Molecular Biology|March 4, 2000
Topoisomerase II as a target for anticancer drugs: when enzymes stop being niceJ M Fortune, N Osheroff
Chemical Research in Toxicology|September 1, 1993
When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugsA H Corbett, N Osheroff
Pageof 37

Showing results (61-70 of 362) with videos related to

Sort By:
Pageof 37
The Journal of Biological Chemistry|February 13, 1999
In vitro evolution of preferred topoisomerase II DNA cleavage sitesD A Burden, N Osheroff
Chemical Research in Toxicology|February 26, 2008
(-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerasesOmari J Bandele, Neil Osheroff
Phytochemistry Reviews : Proceedings of the Phytochemical Society of Europe|March 29, 2014
Phytochemicals as Anticancer and Chemopreventive Topoisomerase II PoisonsAdam C Ketron, Neil Osheroff
ACS Infectious Diseases|January 27, 2026
Enzyme-DNA Interactions Affect the Catalytic Inhibition of Mycobacterial Gyrases by Antibacterial DrugsJillian F Armenia, Neil Osheroff
ACS Infectious Diseases|April 2, 2024
Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone ResistanceJessica A Collins, Neil Osheroff
Biochemistry|July 14, 1987
Calcium-promoted DNA cleavage by eukaryotic topoisomerase II: trapping the covalent enzyme-DNA complex in an active formN Osheroff, E L Zechiedrich
Biochemistry|August 24, 2005
Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzymeJennifer S Dickey, Neil Osheroff
Biochemistry|March 1, 2006
The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugsA Kathleen McClendon, Neil Osheroff
Progress in Nucleic Acid Research and Molecular Biology|March 4, 2000
Topoisomerase II as a target for anticancer drugs: when enzymes stop being niceJ M Fortune, N Osheroff
Chemical Research in Toxicology|September 1, 1993
When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugsA H Corbett, N Osheroff
Pageof 37